Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

VNDAVNDA
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in VANDA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 1M shares of VNDA (VANDA PHARMACEUTICALS INC), worth $6.3M as of 2026-Q2. The position was increased (+23.6% shares). VNDA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$6.3M

Current Shares

1M

Total Value Change

+$2.6M

Total Shares Change

+248,443

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+23.6%
$6.3M0.0%$6.12
33
2026-Q1
Increased
838,233
+105.3%
$5.8M0.0%$7.84
44
2025-Q4
Increased
408,342
+20.2%
$3.6M0.0%$7.03
32
2025-Q3
Decreased
339,701
-16.5%
$1.7M0.0%$4.91
0
2025-Q2
Decreased
406,731
-41.4%
$1.9M0.0%$4.78
0
2025-Q1
Decreased
693,852
-11.9%
$3.2M0.0%$4.69
0
2024-Q4
New
787,817
-
$3.8M0.0%$4.78
37

Other major holders of VNDA: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used